Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Asset Utilization Ratio (2022 - 2025)

Dianthus Therapeutics has reported Asset Utilization Ratio over the past 4 years, most recently at 0.01 for Q3 2025.

  • Quarterly results put Asset Utilization Ratio at 0.01 for Q3 2025, down 54.09% from a year ago — trailing twelve months through Sep 2025 was 0.01 (down 54.09% YoY), and the annual figure for FY2024 was 0.02, up 4.66%.
  • Asset Utilization Ratio for Q3 2025 was 0.01 at Dianthus Therapeutics, down from 0.01 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for DNTH hit a ceiling of 0.1 in Q2 2023 and a floor of 0.01 in Q3 2025.
  • Median Asset Utilization Ratio over the past 4 years was 0.02 (2024), compared with a mean of 0.03.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 88.68% in 2024 and later surged 57.35% in 2025.
  • Dianthus Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then tumbled by 70.64% to 0.02 in 2023, then rose by 12.66% to 0.02 in 2024, then tumbled by 60.21% to 0.01 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.02 (Q1 2025) per Business Quant data.